Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group

Blood (2020) 136 (19): 2103–2117.

https://doi.org/10.1182/blood.2020005221

Published: 2020

Includes: Supplemental data

Journal Articles

Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome

Elizabeth C. Schramm, Lubka T. Roumenina, Tania Rybkine, Sophie Chauvet, Paula Vieira-Martins, Christophe Hue, Tara Maga, Elisabetta Valoti, Valerie Wilson, Sakari Jokiranta, Richard J. H. Smith, Marina Noris, Tim Goodship, John P. Atkinson, Veronique Fremeaux-Bacchi

Blood (2015) 125 (15): 2359–2369.

https://doi.org/10.1182/blood-2014-10-609073

Published: 2015

Includes: Supplemental data

Journal Articles

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy

Marina Noris, Miriam Galbusera, Sara Gastoldi, Paolo Macor, Federica Banterla, Elena Bresin, Claudio Tripodo, Serena Bettoni, Roberta Donadelli, Elisabetta Valoti, Francesco Tedesco, Alessandro Amore, Rosanna Coppo, Piero Ruggenenti, Eliana Gotti, Giuseppe Remuzzi

Blood (2014) 124 (11): 1715–1726.

https://doi.org/10.1182/blood-2014-02-558296

Published: 2014

Includes: Supplemental data

Journal Articles

Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura

Luca A. Lotta, Haifeng M. Wu, Ian J. Mackie, Marina Noris, Agnes Veyradier, Marie A. Scully, Giuseppe Remuzzi, Paul Coppo, Ri Liesner, Roberta Donadelli, Chantal Loirat, Richard A. Gibbs, April Horne, Shangbin Yang, Isabella Garagiola, Khaled M. Musallam, Flora Peyvandi

Blood (2012) 120 (2): 440–448.

https://doi.org/10.1182/blood-2012-01-403113

Published: 2012

Includes: Supplemental data

Journal Articles

Residual Plasmatic Activity of ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura Correlates with Disease Phenotype

Luca A Lotta, Haifeng M Wu, Marie A Scully, Marina Noris, Agnes Veyradier, Ian J Mackie, PhD FRCPath, Giuseppe Remuzzi, Paul Coppo, Ri Liesner, Roberta Donadelli, Chantal Loirat, MD, Richard A Gibbs, April Horne, Shangbin Yang, Roberta Palla, Flora Peyvandi

Blood (2011) 118 (21): 2219.

https://doi.org/10.1182/blood.V118.21.2219.2219

Published: 2011

Journal Articles

Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome

Celia J. Fang, Veronique Fremeaux-Bacchi, M. Kathryn Liszewski, Gaia Pianetti, Marina Noris, Timothy H. J. Goodship, John P. Atkinson

Blood (2008) 111 (2): 624–632.

https://doi.org/10.1182/blood-2007-04-084533

Published: 2008

Includes: Supplemental data

Journal Articles

Genetics of HUS: the impact of MCP, CFH , and IF mutations on clinical presentation, response to treatment, and outcome

Jessica Caprioli, Marina Noris, Simona Brioschi, Gaia Pianetti, Federica Castelletti, Paola Bettinaglio, Caterina Mele, Elena Bresin, Linda Cassis, Sara Gamba, Francesca Porrati, Sara Bucchioni, Giuseppe Monteferrante, Celia J. Fang, M. K. Liszewski, David Kavanagh, John P. Atkinson, Giuseppe Remuzzi, for the International Registry of Recurrent and Familial HUS/TTP

Blood (2006) 108 (4): 1267–1279.

https://doi.org/10.1182/blood-2005-10-007252

Published: 2006

Journal Articles

Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case report

Miriam Galbusera, Elena Bresin, Marina Noris, Sara Gastoldi, Daniela Belotti, Cristina Capoferri, Erica Daina, Paolo Perseghin, Friedrich Scheiflinger, Fadi Fakhouri, Jean-Pierre Grünfeld, Enrico Pogliani, Giuseppe Remuzzi

Blood (2005) 106 (3): 925–928.

https://doi.org/10.1182/blood-2004-12-4885

Published: 2005

Journal Articles

Diverse Functional Implications of ADAMTS13 Gene Mutations in Patients with TTP and Congenital Deficiency.

Roberta Donadelli, Biol.Sci.D, Federica Banterla, Biol.Sci.D, Cristina Capoferri, Biol.Sci.D, Miriam Galbusera, Biol.Sci.D, Zaverio M. Ruggeri, M.D., Sara Bucchioni, Biol.Sci.D, Marina Noris, Chem Pharm D, Giuseppe Remuzzi, M.D.

Blood (2004) 104 (11): 513.

https://doi.org/10.1182/blood.V104.11.513.513

Published: 2004

Journal Articles

von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

Giuseppe Remuzzi, Miriam Galbusera, Marina Noris, Maria Teresa Canciani, Erica Daina, Elena Bresin, Silvia Contaretti, Jessica Caprioli, Sara Gamba, Piero Ruggenenti, Norberto Perico, Pier Mannuccio Mannucci

Blood (2002) 100 (3): 778–785.

https://doi.org/10.1182/blood-2001-12-0166

Published: 2002

Journal Articles

Uremic Bleeding: Closing the Circle After 30 Years of Controversies?

Marina Noris, Giuseppe Remuzzi

Blood (1999) 94 (8): 2569–2574.

https://doi.org/10.1182/blood.V94.8.2569.420k13_2569_2574

Published: 1999

Journal Articles

Increased Fragmentation of von Willebrand Factor, Due to Abnormal Cleavage of the Subunit, Parallels Disease Activity in Recurrent Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura and Discloses Predisposition in Families

Miriam Galbusera, Marina Noris, Chiara Rossi, Silvia Orisio, Jessica Caprioli, Zaverio M. Ruggeri, Barbara Amadei, Piero Ruggenenti, Beatrice Vasile, Giorgio Casari, Giuseppe Remuzzi

Blood (1999) 94 (2): 610–620.

https://doi.org/10.1182/blood.V94.2.610

Published: 1999

NARROW

Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group

Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy

Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura

Residual Plasmatic Activity of ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura Correlates with Disease Phenotype

Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome

Genetics of HUS: the impact of MCP, CFH , and IF mutations on clinical presentation, response to treatment, and outcome

Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case report

Diverse Functional Implications of ADAMTS13 Gene Mutations in Patients with TTP and Congenital Deficiency.

von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

Uremic Bleeding: Closing the Circle After 30 Years of Controversies?

Increased Fragmentation of von Willebrand Factor, Due to Abnormal Cleavage of the Subunit, Parallels Disease Activity in Recurrent Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura and Discloses Predisposition in Families

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only